Join to view full profile
181 S Buena Vista St4RTH floorBurbank, CA 91505
Phone+1 818-840-0921
Fax+1 818-840-7064
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Edwin Jacobs, MD is an oncologist in Burbank, California. He is currently licensed to practice medicine in California, Mississippi, and Tennessee.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
David Geffen School of Medicine at UCLAClass of 1985
Certifications & Licensure
MS State Medical License 2025 - 2027
TN State Medical License 2025 - 2027
CA State Medical License 1988 - 2025
CA State Medical License 1988 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2013
Publications & Presentations
PubMed
- 3 citationsEvaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.Robert A. Figlin, John Crowley, Edwin L. Jacobs, Michael Muirhead, John Wendall Goodwin
Cancer. 1996-09-01 - 32 citationsAlterations in phenotype and cell‐surface antigen expression levels of human monocytes: Differential response to in vivo administration of rhm‐csf or rhgm‐csfIngrid Schmid, Gayle Cocita Baldwin, Edwin L. Jacobs, Valentin Isacescu, Negoita Neagos
Cytometry. 1995-06-15 - 4 citationsA comparative study of intravenous versus intralymphatic interleukin-2, with assessment of effects of interleukin-2 on both peripheral blood and thoracic-duct lymph.Gregory Sarna, Herbert Machleder, James Collins, Benjamin Bonavida, Edwin L. Jacobs
Journal of Immunotherapy With Emphasis on Tumor Immunology. 1994-02-01










